Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions

RE Harskamp, RD Lopes, CE Baisden… - Annals of …, 2013 - journals.lww.com
Objective: To review our current understanding of the epidemiology and pathogenesis of
vein graft failure (VGF), give an overview of current preventive and interventional measures …

Impact of cardiac rehabilitation and exercise training programs in coronary heart disease

S Kachur, V Chongthammakun, CJ Lavie… - Progress in …, 2017 - Elsevier
Cardiovascular rehabilitation (CR) is the process of developing and maintaining an optimal
level of physical, social, and psychological well-being in order to promote recovery from …

Microfluidic bioprinting of tough hydrogel-based vascular conduits for functional blood vessels

D Wang, S Maharjan, X Kuang, Z Wang, LS Mille… - Science …, 2022 - science.org
Three-dimensional (3D) bioprinting of vascular tissues that are mechanically and
functionally comparable to their native counterparts is an unmet challenge. Here, we …

Surgical site infection in cardiac surgery

A Zukowska, M Zukowski - Journal of Clinical Medicine, 2022 - mdpi.com
Surgical site infections (SSIs) are one of the most significant complications in surgical
patients and are strongly associated with poorer prognosis. Due to their aggressive …

Understanding the volume-outcome effect in cardiovascular surgery: the role of failure to rescue

AA Gonzalez, JB Dimick, JD Birkmeyer… - JAMA …, 2014 - jamanetwork.com
Importance To effectively guide interventions aimed at reducing mortality in low-volume
hospitals, the underlying mechanisms of the volume-outcome relationship must be further …

[HTML][HTML] Stopping vs. continuing aspirin before coronary artery surgery

PS Myles, JA Smith, A Forbes, B Silbert… - … England Journal of …, 2016 - Mass Medical Soc
Background Most patients with coronary artery disease receive aspirin for primary or
secondary prevention of myocardial infarction, stroke, and death. Aspirin poses a risk of …

2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and …

FG Bakaeen, M Gaudino, G Whitman, T Doenst… - The Journal of thoracic …, 2021 - jtcvs.org
2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary
artery bypass grafting in patients with ischemic cardiomyopathy and heart failure - The Journal …

Dual antiplatelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and metaanalysis

SV Deo, SM Dunlay, IK Shah… - Journal of Cardiac …, 2013 - Wiley Online Library
Background Antiplatelet therapy is an important component of medical therapy post
coronary artery bypass grafting (CABG). While aspirin administration is a Class I indication …

Management and prevention of saphenous vein graft failure: a review

P McKavanagh, B Yanagawa, G Zawadowski… - Cardiology and …, 2017 - Springer
Coronary artery bypass grafting (CABG) remains a vital treatment for patients with
multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the …

The SYNTAX score and its clinical implications

SJ Head, V Farooq, PW Serruys, AP Kappetein - Heart, 2014 - heart.bmj.com
Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are
both treatment options for coronary revascularisation in selected patients with stable …